Japanese CRO JCL Bioassay Sales And Profits Increase
This article was originally published in PharmAsia News
Executive Summary
Japanese contract research organization JCL Bioassay announced April 30 results for FY2008. The company achieved a record ¥2.48 billion in sales, a 7 percent increase. The company's business profit increased by 40.6 percent to ¥502 million, regular profit increased by 32.3 percent to ¥437 million, and net profit increased by 11.3 percent to ¥259 million. Bioanalysis service accounts for 80 percent of JCL Bioassay's sales. For the fiscal year 2009, JCL Bioassay estimates sales, business profit and regular profit increases by 3.5, 11.2 and 3.8 percent, respectively. The company cites a continuous outsourcing trend in pharmaceutical companies. (Click here for more - Japanese language